RT @biogerontology: Our NB paper will be presented tomorrow at Basel Life https://t.co/cyafxr1ZK5
Deep learning enables rapid identification of potent DDR1 kinase inhibitors #DataDC https://t.co/yI5gOCIebO @nature @StatProgDC
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @FuturistAvenue: Custom compound visualized by deep learning AI successfully validated in mice 💉🐀 📰 Read on: https://t.co/MGQ3MRWO63 💡…
Custom compound visualized by deep learning AI successfully validated in mice 💉🐀 📰 Read on: https://t.co/MGQ3MRWO63 💡 Research paper: https://t.co/grtHLvUDN2 #HealthTech 🏷 #ArtificialIntelligence 🏷 #deeplearning 🏷 #biotechnology
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/JMyaRl…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/JMyaRlO52S #DeepLearning #Iot
RT @InSilicoMeds: Biggest News Today. Insilico Medicine's team made a breakthrough in AI for drug discovery last year. Today we are far ah…
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @biogerontology: Our NB paper will be presented tomorrow at Basel Life https://t.co/cyafxr1ZK5
RT @BioDecoded: Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/nugg2V3yjl…
RT @biogerontology: Our NB paper will be presented tomorrow at Basel Life https://t.co/cyafxr1ZK5
RT @biogerontology: Our NB paper will be presented tomorrow at Basel Life https://t.co/cyafxr1ZK5
RT @biogerontology: Our NB paper will be presented tomorrow at Basel Life https://t.co/cyafxr1ZK5
RT @biogerontology: Our NB paper will be presented tomorrow at Basel Life https://t.co/cyafxr1ZK5
Our NB paper will be presented tomorrow at Basel Life https://t.co/cyafxr1ZK5
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @machinelearnflx: Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/7kZyxmjnBZ #DeepLearning
Deep learning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/KXxvKmaEWL #DeepLearning
RT @biogerontology: Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement…
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
Deep learning enables rapid identification of potent DDR1 kinase inhibitors #insilico #insilicomedicine #ai #DDR1, #Nature #insilicomeds, published in #NatureBiotech, #InsilicoAI @biogerontology https://t.co/86N7PmMq1l
Deep learning enables rapid identification of potent DDR1 kinase inhibitors #insilico #insilicomedicine #ai #DDR1, #Nature #insilicomeds, published in #NatureBiotech, #InsilicoAI @biogerontology https://t.co/iLGvPsizBj
RT @DruggableGenome: A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
A cool application of AI for small molecule drug discovery: https://t.co/vQ4etExulj
RT @biogerontology: Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement…
RT @biogerontology: Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement…
RT @biogerontology: Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement…
RT @biogerontology: Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @biogerontology: Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @jason_pontin: The publication of this paper by Alex Zhavoronkov et al was actually the most important thing that happened last week. (N…
RT @biogerontology: Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement…
Now my life has one more purpose. I want to publish papers that eclipse politics and celebrities. The main achievement of AlphaGo was that 2 billion people watched it. Now everyone wants to be an AI scientist. We need this in pharma. Make drug discovery fa
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @SimonFlyvbjerg: Impressive proof-of-principle for #AI in drug discovery. "In this work, we designed, synthesized, and experimentally va…
RT @biogerontology: Deeply humbled to see our work among the 5 Coolest Things On Earth This Week by GE https://t.co/Pkv8Nx2rK1 And the ori…
RT @biogerontology: Deeply humbled to see our work among the 5 Coolest Things On Earth This Week by GE https://t.co/Pkv8Nx2rK1 And the ori…
RT @InSilicoMeds: Experimental validation of molecules "imagined" by next-gen artificial intelligence https://t.co/GORcuUlDye #ArtificialI…
RT @biogerontology: Deeply humbled to see our work among the 5 Coolest Things On Earth This Week by GE https://t.co/Pkv8Nx2rK1 And the ori…
RT @biogerontology: Deeply humbled to see our work among the 5 Coolest Things On Earth This Week by GE https://t.co/Pkv8Nx2rK1 And the ori…
RT @biogerontology: Deeply humbled to see our work among the 5 Coolest Things On Earth This Week by GE https://t.co/Pkv8Nx2rK1 And the ori…
RT @nresearchnews: A @NatureBiotech paper describes a machine learning model that allows for the identification of new small-molecule kinas…
RT @d_polykovskiy: Check our new paper in @NatureBiotech on generation and testing of small molecules with variational inference, tensor de…
RT @biogerontology: Deeply humbled to see our work among the 5 Coolest Things On Earth This Week by GE https://t.co/Pkv8Nx2rK1 And the ori…
Deeply humbled to see our work among the 5 Coolest Things On Earth This Week by GE https://t.co/Pkv8Nx2rK1 And the original paper just in case https://t.co/cyafxr1ZK5
RT @Datascience__: Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/7kZyxmjn…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/7kZyxmjnBZ #DeepLearning
RT @josephfdonahue: Are there any other chemists out there that are just thinking 'wow' after reading this? https://t.co/61Woz0FDsg #ai #…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
Deep learning enables rapid identification of potent DDR1 kinase inhibitors. https://t.co/TTo5iWY8yS
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @BioDecoded: Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/nugg2V3yjl…
RT @biogerontology: New AI Model Shortens Drug Discovery to Days, Not Years | Psychology Today https://t.co/MudhyH8zYv Please consider loo…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @SimonFlyvbjerg: Impressive proof-of-principle for #AI in drug discovery. "In this work, we designed, synthesized, and experimentally va…
RT @InSilicoMeds: Experimental validation of molecules "imagined" by next-gen artificial intelligence https://t.co/GORcuUlDye #ArtificialI…
@eperlste I've been wondering what #sciencetwitter thought of that paper 😂 I presume you mean this one: I've been wondering what #sciencetwitter thought of that paper. I presume you mean this one: https://t.co/jqjn5ELYx7
RT @InSilicoMeds: Experimental validation of molecules "imagined" by next-gen artificial intelligence https://t.co/GORcuUlDye #ArtificialI…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @InSilicoMeds: Experimental validation of molecules "imagined" by next-gen artificial intelligence https://t.co/GORcuUlDye #ArtificialI…
Experimental validation of molecules "imagined" by next-gen artificial intelligence https://t.co/GORcuUlDye #ArtificialInteligence, #drugdiscovery, #DeepLearning
RT @Reza_Zadeh: Model generates a novel drug in 21 days, & after 25 more days of synthesis & testing, its predicted biological & chemical p…
RT @SimonFlyvbjerg: Impressive proof-of-principle for #AI in drug discovery. "In this work, we designed, synthesized, and experimentally va…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
Impressive proof-of-principle for #AI in drug discovery. "In this work, we designed, synthesized, and experimentally validated molecules targeting DDR1 kinase in less than 2 months and for a fraction of the cost associated with a traditional drug discovery
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
AI designed drug targeted at fibrosis disease within days instead of years at a fraction of the cost of traditional drug discovery 🤖>🔬 #ArtificialIntelligence | #biotech | #AUTOMATION | #AI | #HealthTech https://t.co/grtHLvUDN2
RT @biogerontology: New AI Model Shortens Drug Discovery to Days, Not Years | Psychology Today https://t.co/MudhyH8zYv Please consider loo…
RT @Datascience__: Deep learning enables rapid identification of potent DDR1 kinase inhibitors | Nature Biotechnology https://t.co/7kZyxmjn…
RT @DianacBiggs: This is exciting: #AI is making drug discovery a faster process. Congrats @biogerontology on the @nature publication https…
RT @BaselLSW: The breakthrough AI work on generative chemistry to be presented at #BASELLIFE19 at the #agingpharma forum: https://t.co/nQpz…
RT @GeorgeSeif94: Excellent application of #DeepLearning. Healthcare is a massive field where AI can be applied and will most definitely ha…
Excellent application of #DeepLearning. Healthcare is a massive field where AI can be applied and will most definitely have a highly positive impact
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
The breakthrough AI work on generative chemistry to be presented at #BASELLIFE19 at the #agingpharma forum: https://t.co/nQpz6Gk32i #deeplearning #GENTRL #AI
RT @biogerontology: Our friends traveling to Basel for our annual #AgingPharma forum at #basellife #basel2019 next week should get an umbre…
Congrats on advancing this new field
RT @biogerontology: Our friends traveling to Basel for our annual #AgingPharma forum at #basellife #basel2019 next week should get an umbre…
RT @postmachines: It's a great honor to be a part of this work. Deep Learning can solve small molecule design! Drug discovery will never be…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @biogerontology: AI developed by @InSilicoMeds and @A_Aspuru_Guzik "imagined" new molecules that were synthesized, tested in human cel…
RT @NatureBiotech: #Deeplearning enables rapid identification of potent DDR1 kinase inhibitors https://t.co/9hyDYFCm7f https://t.co/sNBZDZm…
RT @DianacBiggs: This is exciting: #AI is making drug discovery a faster process. Congrats @biogerontology on the @nature publication https…
یه مقالهای توی Nature منتشر شده که واقعا جالبه... در حد فهم من البته... شرکت اسمش Insilico Medicin @InSilicoMeds این شرکت از هوش مصنوعی توی توسعه دارو استفاده میکنه... https://t.co/orRwTw2JhL
This is exciting: #AI is making drug discovery a faster process. Congrats @biogerontology on the @nature publication https://t.co/Ih6bHSLCsm #biotechnology #deeplearning
RT @EricTopol: There's been a lot of buzz about #AI for drug discovery. But I think this is the best case yet: All in 46 days! https://t.co…
RT @biogerontology: Our friends traveling to Basel for our annual #AgingPharma forum at #basellife #basel2019 next week should get an umbre…